Ultragenyx Sells PRV for $210M | The CheckRare Brief Ep 11 by CheckRare Staff| Published on: Oct 14, 2026

Ultragenyx Sells PRV for $210M | The CheckRare Brief Ep 11 by CheckRare Staff| Published on: Oct 14, 2026 In this episode, we discuss Ultragenyx’s Priority Review Voucher that sold for $210 million, the efficacy of newborn screening on MLD, and ethical considerations needed to design and conduct clinical trials. https://checkrare.com/ultragenyx-sells-prv-for-210m-the-checkrare-brief-ep-11/